Daniel A. Heller: Research Overview

Daniel A. Heller: Research Overview

Share
Share

Cancer Nanomedicine Laboratory

We are inventing novel technologies to treat advanced cancers and to detect disease at early stages. We are a young bioengineering laboratory that develops new nanotechnologies, including nanomedicines—tiny particles that target drugs to tumor sites, and nanosensors—tiny devices that detect markers of disease.

We are developing nanomedicines to target precision agents to disease sites, including to metastatic cancers. We are also addressing the problem of the early detection of cancer and other diseases by building implantable nanosensors. To enable the discovery of new medicines, we also inventing new nanosensors and imaging tools to accelerate drug development and biomedical research. Please check our recent publications and projects.